In the new GFATM funding round, harm reduction is marked as a programme essential. The Global Fund requires each applying country to describe their plan for implementing harm reduction services. This offers a unique opportunity to increase the funding for…

Mainline is starting a two-year project in Recife, Brazil, with LANPUD, and the Free School for Harm Reduction (ELRD). The project aims to expand harm reduction and HIV care and support for young people who use crack cocaine.

Mainline’s research on the use of anabolic androgenic steroids (AAS) and other image- and performance-enhancing drugs is published in the magazine European Addiction Research. 

A team of three Mainline researchers worked in close collaboration with the Zimbabwe Civil Liberties Drug Network throughout 2022 to assess the drug scene in five provinces in Zimbabwe. The full report is out now!

Mainline proudly offers technical assistance to Best Shelter, an NGO in Myanmar. Mainline will work alongside of Best Shelter to improve and upscale their mental health responses. 

Our research ‘Slamming in the Netherlands’ has been published in the international magazine Sexual Health and in the Dutch magazine Tijdschrift voor Seksuologie. Two well-established magazines. And then came the Lancet..

Do you want to know more about the latest research on the use of image and performance enhancing drugs (IPEDs)? Then join us online to attend the Open Lecture Series on Next Frontiers in IPEDs Research organized by the Mindful…

Mainline is asked to review the current harm reduction programmes in Nepal from the perspective of women who inject drugs. Based on interviews with women we hope to formulate recommendations to improve service delivery. 

From a distance, Porte de la Villette looks like a colourful park. A small market perhaps, buzzing with people. But on closer inspection, the scene changes. Once in the park there is little left of the bright image. A very…